National Research (NRC) Status Update summary
Event summary combining transcript, slides, and related documents.
Status Update summary
3 Feb, 2026AI's role in healthcare experience management
AI is being leveraged to reduce administrative burdens, enabling care teams to focus more on patient relationships and empathy.
Modern AI tools are designed to listen to patient and workforce feedback across diverse channels, addressing gaps in traditional survey methods.
AI solutions like Huey are positioned as supplements to staff, enhancing rather than replacing human roles.
Co-design with healthcare partners ensures AI tools are tailored to real-world needs and values.
Unmet needs and market challenges
Key unmet needs include access to care, price transparency, billing clarity, care coordination, and workforce burnout.
Data overload and disconnected data sources hinder actionable insights for healthcare leaders.
Personalization and effective listening remain significant gaps in patient experience.
Huey AI engine: Differentiation and capabilities
Huey is purpose-built for healthcare experience management, integrating structured and unstructured data for actionable insights.
The engine synthesizes large data sets, simplifies repetitive tasks, detects anomalies, and supports decision-making.
Huey is co-designed with partners, ensuring alignment with real-world workflows and needs.
Initial use cases include summarizing patient feedback, enhancing service recovery, expanding listening channels, and providing clinician insights.
Latest events from National Research
- Q4 2025 revenue rose 2%, TRCV up 8% YoY, and a $0.16 dividend was declared.NRC
Q4 20253 Feb 2026 - Timely, representative feedback and focus on key drivers accelerate patient experience improvement.NRC
Status update2 Feb 2026 - Significant CAHPS and HCAHPS survey changes and reporting updates are set for 2025–2030.NRC
Status Update22 Jan 2026 - AI and digital tools can transform healthcare if implemented transparently and with human well-being at the core.NRC
Status Update13 Jan 2026 - 2025 proxy seeks approval for director elections, auditor, say-on-pay, and new incentive plan.NRC
Proxy Filing2 Dec 2025 - TRCV grew 2% as Q2 2025 revenue fell and executive compensation drove a net loss.NRC
Q2 202516 Nov 2025 - Q3 2025 saw higher adjusted EBITDA, record retention, and a 33% dividend increase.NRC
Q3 20257 Nov 2025 - Revenue and net income declined, but cash flow and shareholder returns increased.NRC
Q3 202413 Jun 2025 - Revenue and net income fell, but acquisitions and product innovation signal future growth.NRC
Q2 202413 Jun 2025